| Code | CSB-RA002873MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to ICT-01, targeting BTN3A1 (Butyrophilin Subfamily 3 Member A1), a cell surface glycoprotein belonging to the immunoglobulin superfamily. BTN3A1 plays a critical role in regulating Vγ9Vδ2 T cell activation through recognition of phosphoantigens that accumulate in transformed or infected cells. This protein functions as a key mediator in innate immune surveillance, bridging metabolic stress signals with adaptive immune responses. BTN3A1 is expressed on various cell types and has emerged as an important target in cancer immunology, particularly in the context of tumor immune evasion and γδ T cell-based immunotherapy strategies.
ICT-01 is a well-characterized reference antibody that has been utilized in studies investigating BTN3A1's role in immune regulation and its potential as a therapeutic target. This biosimilar antibody provides researchers with a reliable tool for exploring BTN3A1-mediated immune mechanisms, studying γδ T cell biology, and investigating novel immunotherapeutic approaches in oncology and infectious disease research.
There are currently no reviews for this product.